FDA flags Omnipod 5 recall and Accolade pacemaker safety alert

The FDA is warning patients and clinicians about two separate device-safety issues: a Class I recall for certain Omnipod 5 pods and a safety communication about Boston Scientific Accolade pacemakers that may need earlier replacement in some patients. If you use one of these devices, the key next step is to confirm whether your specific product is affected and follow the official instructions.

These are not the same kind of notice. A recall means a product is being removed or corrected because it may pose a serious risk; a safety communication is the FDA’s way of warning patients and clinicians about a potential problem and what to watch for. In both cases, the goal is to catch problems early and reduce the chance of harm.

Omnipod 5: certain pods are being recalled

The FDA says the Omnipod 5 recall involves certain pod lots that may have a tear in internal tubing, which could let insulin leak inside the pod instead of reaching the body as intended. That can lead to under-delivery of insulin, high blood sugar, and in severe cases diabetic ketoacidosis, which needs prompt medical treatment.

One important concern is that the issue may not always trigger an alarm. The FDA says some users may get a hazard alarm, but in other cases there may be no alert at all, so the problem could go unnoticed.

The FDA says affected users should not use impacted pods. Insulet’s updated notice expanded the list to include expired affected pods and told users not to rely only on alarms to know whether something is wrong. As of April 17, the FDA said Insulet had reported 29 serious injuries and no deaths tied to this issue.

Accolade pacemakers: why follow-up matters

For Boston Scientific Accolade pacemakers and related cardiac resynchronization therapy pacemakers, the FDA warned about the potential need for early replacement in some patients. The issue involves a manufacturing problem with some device batteries that can cause the pacemaker to permanently enter Safety Mode, which limits function and may affect the device’s ability to regulate heart rhythm properly.

The FDA says patients should continue routine monitoring, whether remotely or in the office, and should talk with their clinician if monitoring shows the device entered Safety Mode. People with new or worsening symptoms such as lightheadedness or loss of consciousness should contact their health care team promptly.

For clinicians, the FDA’s message is nuanced: general preventive replacement is not recommended for everyone, but patients who are at higher risk if the device enters Safety Mode may need earlier action based on their pacing needs and follow-up results.

Recall versus safety communication

In plain language, a recall usually means a product problem is serious enough that the manufacturer is removing or correcting it. The FDA classified the Omnipod 5 action as a Class I recall, its most serious type. A safety communication, by contrast, is an alert that helps patients and clinicians understand a possible risk and decide how to monitor or respond.

That distinction matters because the next step is different. For the Omnipod 5 issue, the advice is to check lot numbers and stop using affected pods. For the pacemaker issue, the advice is to stay in follow-up and let the device clinic or cardiology team decide whether replacement is needed.

What readers can do now

• Check your device paperwork, packaging, or clinic records for the exact model or lot number.
• Use the manufacturer’s or FDA’s official notice to confirm whether your device is affected.
• Call the manufacturer or your device clinic if you are unsure how to interpret the label or serial number.
• For insulin users, make sure you have a backup plan for insulin delivery if affected pods run short.
• For pacemaker patients, do not skip scheduled remote checks or office visits.

If you have symptoms that could be urgent — such as severe high blood sugar, vomiting, confusion, fainting, chest symptoms, or trouble staying awake — seek urgent or emergency care. For device-specific questions, contact your clinician, pharmacist, or device manufacturer for individualized guidance.

The safest approach is to verify your device status through official notices and talk with your care team before making any changes. Device recalls and safety alerts can be stressful, but they are also meant to give patients and clinicians a chance to act before a problem becomes an emergency.

Sources

• FDA — Insulin Pump Recall: Insulet Removes Certain Omnipod 5 Pods
• FDA — Accolade Pacemaker Devices by Boston Scientific and Potential Need for Early Device Replacement
• FDA Recalls
• FDA — Medical Device Shortages List
• HRS — Revised Notice on Boston Scientific ACCOLADE™ Family Pacemakers
• FDA

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.

Related

• FDA’s new AI labeling push could change how patients and clinicians judge medical devices
• FDA warns of nationwide recall of lactated Ringer’s injection
• FDA Adds Two Device Shortages: Angiographic Syringes and Breast Biopsy Needles
• FDA Flags Neurosurgical Sponge Shortage, B. Braun Recalls IV Fluid